Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition

The American Review of Respiratory Disease
R DworskiG A Fitzgerald

Abstract

Products of arachidonic acid have been implicated as potential mediators of allergic airway responses in sheep and in humans. We therefore measured the release of arachidonate metabolites into sheep bronchoalveolar lavage fluid (BALF) after local instillation of Ascaris antigen, using a highly specific and sensitive approach, gas chromatography-negative ion-chemical ionization mass spectrometry. Allergen instillation caused increases in the levels of the potent bronchoconstrictors prostaglandin (PG) D2 and thromboxane (TX) A2 (as reflected by levels of TXB2) and of their enzymatic metabolites, 9 alpha, 11 beta-PGF2 and 11-dehydro-TXB2, respectively. Potential bronchodilators, PGI2 and PGE2, were also formed in increased amounts. Levels of the 5-lipoxygenase products, leukotriene (LT) B4 and C4, were not significantly increased. Pretreatment of sheep with cyclooxygenase inhibitors was associated with a decrease in the release of cyclooxygenase products and a concomitant increase in the allergen-stimulated release of LTB4 and LTC4. Eicosanoids are formed promptly in vivo in sheep after allergen instillation: inhibition of cyclooxygenase results in augmented generation of leukotrienes in the airways of sensitive sheep in response ...Continue Reading

References

Feb 1, 1976·British Journal of Pharmacology·R J FlowerW P Kingston
Oct 1, 1986·Journal of Applied Physiology·S R KleebergerE W Spannhake
Jul 11, 1985·The New England Journal of Medicine·R M NaclerioL M Lichtenstein
Jun 1, 1986·The Journal of Experimental Medicine·D R RobinsonW M Zapol
Apr 1, 1987·Journal of Applied Physiology·S R KleebergerE W Spannhake
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C W LeeK F Austen

❮ Previous
Next ❯

Citations

Mar 1, 1995·Journal of Lipid Mediators and Cell Signalling·N SongürT Matsuda
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R J SebaldtG A FitzGerald
Jun 1, 1990·New Zealand Veterinary Journal·W ChenB W Manktelow
Oct 1, 1992·British Journal of Clinical Pharmacology·R A StoneR W Fuller
Dec 31, 1997·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M FujimuraT Matsuda
Sep 1, 1992·Equine Veterinary Journal·E D WatsonK A Steensma
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·T V HartertJ R Sheller
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·R S PeeblesJ R Sheller
Apr 17, 2002·American Journal of Respiratory and Critical Care Medicine·R Stokes PeeblesJames R Sheller
Dec 1, 1992·The Journal of Clinical Investigation·M RomanoR J Coffey
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·L M LandinoL J Marnett
Mar 15, 2008·Pulmonary Pharmacology & Therapeutics·William M Abraham
Apr 13, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Junko NakataAtsushi Nagai
Mar 11, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lu WangPasquale Chitano
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Weisong ZhouR Stokes Peebles
Oct 12, 2018·International Journal of Molecular Sciences·Wataru SutoYoshihiko Chiba
May 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids· Mucha, A Riutta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ascariasis

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.